News

Published on 2 May 2023 on Simply Wall St. via Yahoo Finance

Strong week for Verastem (NASDAQ:VSTM) shareholders doesn't alleviate pain of five-year loss


Article preview image

It's nice to see the Verastem, Inc. (NASDAQ:VSTM) share price up 15% in a week. But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. In fact, the share price has tumbled down a mountain to land 89% lower after that period. While the recent increase might be a green shoot, we're certainly hesitant to rejoice. The important question is if the business itself justifies a higher share price in the long term. While a drop like that is definitely a body blow, money isn't as important as health and happiness.

While the stock has risen 15% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.

View our latest analysis for Verastem

NASDAQ.VSTM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.01% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.01%

Investing.com 27 May 2024

Crude Oil Rises 1%; Verastem Shares Slide - Verastem (NASDAQ:VSTM)

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than ...

Benzinga 24 May 2024

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 ...

Zacks via Yahoo Finance 24 May 2024

Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...

Needham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as o...

The Business Journals 24 May 2024

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy resul...

Benzinga via AOL 24 May 2024

Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc

Introduction to the Transaction Andreas Halvorsen (Trades, Portfolio)'s Viking Global Investors L...

GuruFocus.com via Yahoo Finance 15 Feb 2024

Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)

On February 6, 2024, Robert Gagnon, a director at Verastem Inc, executed a sale of 9,204 shares o...

GuruFocus.com via Yahoo Finance 7 Feb 2024

Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy

Verastem Oncology VSTM announced that the FDA has granted the Fast Track designation to its inves...

Zacks via Yahoo Finance 24 Jan 2024

Strong week for Verastem (NASDAQ:VSTM) shareholders doesn't alleviate pain of five-year loss

It's nice to see the Verastem, Inc. (NASDAQ:VSTM) share price up 15% in a week. But will that rep...

Simply Wall St. via Yahoo Finance 2 May 2023

10 Top Penny Stocks for 2023

This could be a major catalyst for the company. 9. Galaxy GamingInc (GLXZ) Galaxy Gaming is a cas...

GoBankingRates via AOL 19 Apr 2023